BDX - Why Becton Dickinson and Company Stock Is Trading Lower | Benzinga
Becton Dickinson and Co (NYSE: BDX) shares are trading lower by 2.31% to $261.09 Wednesday afternoon. The stock may be down after the FDA established a Digital Health Advisory Committee.
What Happened?
The FDA has officially launched the Digital Health Advisory Committee, which is dedicated to tackling intricate scientific and technical challenges within the realm of digital health technologies, encompassing areas such as AI, augmented reality, and wearable devices.
This committee is strategically assembled to offer its expertise and unique perspectives to enhance the FDA's comprehension of both the advantages and risks associated with these technologies. It ...